Narlik-Grassow M, Blanco-Aparicio C, Carnero A. The PIM family of serine/threonine kinases in cancer. Med Res Rev. 2014;34(1):136–59. https://doi.org/10.1002/med.21284.

Article  CAS  PubMed  Google Scholar 

Bachmann M, Möröy T. The serine/threonine kinase Pim-1. Int J Biochem Cell Biol. 2005;37(4):726–30. https://doi.org/10.1016/j.biocel.2004.11.005.

Article  CAS  PubMed  Google Scholar 

Nawijn MC, Alendar A, Berns A. For better or for worse: the role of Pim oncogenes in tumorigenesis. Nat Rev Cancer. 2011;11(1):23–34. https://doi.org/10.1038/nrc2986.

Article  CAS  PubMed  Google Scholar 

Zhu N, Ramirez LM, Lee RL, Magnuson NS, Bishop GA, Gold MR. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-κB pathway. J Immunol. 2002;168(2):744–54. https://doi.org/10.4049/jimmunol.168.2.744.

Article  CAS  PubMed  Google Scholar 

Fox CJ, Hammerman PS, Cinalli RM, Master SR, Chodosh LA, Thompson CB. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes & development. 2003;17(15):1841–1854. http://www.genesdev.org/cgi/doi/https://doi.org/10.1101/gad.1105003.

Fujii C, Nakamoto Y, Lu P, Tsuneyama K, Popivanova BK, Kaneko S, Mukaida N. Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines. Int J Cancer. 2005;114(2):209–18. https://doi.org/10.1002/ijc.20719.

Article  CAS  PubMed  Google Scholar 

Qian KC, Wang L, Hickey ER, Studts J, Barringer K, Peng C, et al. Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase. J Biol Chem. 2005;280(7):6130–7. https://doi.org/10.1074/jbc.m409123200.

Article  CAS  PubMed  Google Scholar 

Bullock AN, Russo S, Amos A, Pagano N, Bregman H, Debreczeni JE, et al. Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor. PloS one. 2009;4(10):e7112. https://doi.org/10.1371/2Fjournal.pone.0007112

Blanco-Aparicio C, Carnero A. Pim kinases in cancer: diagnostic, prognostic and treatment opportunities. Biochem Pharmacol. 2013;85(5):629–43. https://doi.org/10.1016/j.bcp.2012.09.018.

Article  CAS  PubMed  Google Scholar 

Julson JR, Marayati R, Beierle EA, Stafman LL. The role of PIM kinases in pediatric solid tumors. Cancers. 2022;14(15):3565. https://doi.org/10.3390/cancers14153565.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amson R, Sigaux F, Przedborski S, Flandrin G, Givol D, Telerman A. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc Natl Acad Sci. 1989;86(22):8857–61. https://doi.org/10.1073/pnas.86.22.8857.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mizuno K, Shirogane T, Shinohara A, Iwamatsu A, Hibi M, Hirano T. Regulation of pim-1 by hsp90. Biochem Biophys Res Commun. 2001;281(3):663–9. https://doi.org/10.1006/bbrc.2001.4405.

Article  CAS  PubMed  Google Scholar 

Petersen Shay K, Wang Z, Xing PX, McKenzie IF, Magnuson NS. Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway. Mol Cancer Res. 2005;3(3):170–81. https://doi.org/10.1158/1541-7786.MCR-04-0192.

Article  CAS  Google Scholar 

Losman JA, Chen XP, Vuong BQ, Fay S, Rothman PB. Protein phosphatase 2A regulates the stability of Pim protein kinases. J Biol Chem. 2003;278(7):4800–5. https://doi.org/10.1074/jbc.M208246200.

Article  CAS  PubMed  Google Scholar 

Ma J, Arnold HK, Lilly MB, Sears RC, Kraft AS. Negative regulation of Pim-1 protein kinase levels by the B56β subunit of PP2A. Oncogene. 2007;26(35):5145–53. https://doi.org/10.1038/sj.onc.1210323.

Article  CAS  PubMed  Google Scholar 

Park YK, Obiang-Obounou BW, Lee KB, Choi JS, Jang BC. AZD1208, a pan-Pim kinase inhibitor, inhibits adipogenesis and induces lipolysis in 3T3-L1 adipocytes. J Cell Mol Med. 2018;22(4):2488–97. https://doi.org/10.1111/jcmm.13559.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kreuz S, Holmes KB, Tooze RM, Lefevre PF. Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas. Mol Cancer. 2015;14:1–4. https://doi.org/10.1186/s12943-015-0477-z.

Article  CAS  Google Scholar 

Yip-Schneider MT, Horie M, Broxmeyer HE. Transcriptional induction of pim-1 protein kinase gene expression by interferon gamma and posttranscriptional effects on costimulation with steel factor. Blood. 1995;85:3494–502. https://doi.org/10.1182/blood.V85.12.3494.bloodjournal85123494.

Article  CAS  PubMed  Google Scholar 

Matikainen S, Sareneva T, Ronni T, Lehtonen A, Koskinen PJ, Julkunen I. Interferon-α Activates Multiple STAT Proteins and Upregulates Proliferation-Associated IL-2Rα, c-myc, and pim-1 Genes in Human T Cells. Blood, The Journal of the American Society of Hematology. 1999;93(6):1980–91. https://doi.org/10.1182/blood.V93.6.1980.406k20_1980_1991.

Article  CAS  Google Scholar 

Block KM, Hanke NT, Maine EA, Baker AF. IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines. Pancreas. 2012;41(5):773–7781. https://doi.org/10.1097/MPA.0b013e31823cdd10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peltola KJ, Paukku K, Aho TL, Ruuska M, Silvennoinen O, Koskinen PJ. Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3. Blood. 2004;103(10):3744–50. https://doi.org/10.1182/blood-2003-09-3126.

Article  CAS  PubMed  Google Scholar 

Shirogane T, Fukada T, Muller JM, Shima DT, Hibi M, Hirano T. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity. 1999;11(6):709–19. https://doi.org/10.1016/S1074-7613(00)80145-4.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Wang Z, Li X, Magnuson NS. Pim kinase-dependent inhibition of c-Myc degradation. Oncogene. 2008;35:4809–19. https://doi.org/10.1038/onc.2008.123.

Article  CAS  Google Scholar 

Horiuchi D, Camarda R, Zhou AY, Yau C, Momcilovic O, Balakrishnan S, et al. PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression. Nat Med. 2016;11:1321–9. https://doi.org/10.1038/nm.4213.

Article  CAS  Google Scholar 

Macdonald A, Campbell DG, Toth R, McLauchlan H, Hastie CJ, Arthur JS. Pim kinases phosphorylate multiple sites on Bad and promote 14–3–3 binding and dissociation from Bcl-X L. BMC cell biology. 2006:1–4. https://doi.org/10.1186/1471-2121-7-1

Gu JJ, Wang Z, Reeves R, Magnuson NS. PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis. Oncogene. 2009;48:4261–71. https://doi.org/10.1038/onc.2009.276.

Article  CAS  Google Scholar 

Hu YL, Passegué E, Fong S, Largman C, Lawrence HJ. Evidence that the Pim1 kinase gene is a direct target of HOXA9. Blood, The Journal of the American Society of Hematology. 2007;109(11):4732–8. https://doi.org/10.1182/blood-2006-08-043356.

Article  CAS  Google Scholar 

Brault L, Gasser C, Bracher F, Huber K, Knapp S, Schwaller J. PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. haematologica. 2010;95(6):1004. https://doi.org/10.3324/haematol.2009.017079

Nihira K, Ando Y, Yamaguchi T, Kagami Y, Miki Y, Yoshida K. Pim-1 controls NF-κB signalling by stabilizing RelA/p65. Cell Death Differ. 2010;4:689–98. https://doi.org/10.1038/cdd.2009.174.

Article  CAS  Google Scholar 

Rout AK, Dehury B, Parida SN, Rout SS, Jena R, Kaushik N, et al. A review on structure-function mechanism and signaling pathway of serine/threonine protein PIM kinases as a therapeutic target. International Journal of Biological Macromolecules. 2024:132030. https://doi.org/10.1016/j.ijbiomac.2024.132030

Panchal NK, Sabina EP. A serine/threonine protein PIM kinase as a biomarker of cancer and a target for anti-tumor therapy. Life Sci. 2020;255: 117866. https://doi.org/10.1016/j.lfs.2020.117866.

Article  CAS  PubMed  Google Scholar 

Zhang X, Song M, Kundu JK, Lee MH, Liu ZZ. PIM kinase as an executional target in cancer. Journal of Cancer Prevention. 2018;23(3):109. https://doi.org/10.15430/JCP.2018.23.3.109

Liu XJ, Xiao QL, Wu X, Jin M, Shan T. Differential expression and clinical characteristics of Pim1 protein in different lesions of breast. Journal of Hainan Medical University. 2019;25(1):40–4.